Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.
source https://medicalxpress.com/news/2025-10-mrna-based-covid-vaccines-generate.html
source https://medicalxpress.com/news/2025-10-mrna-based-covid-vaccines-generate.html
Comments
Post a Comment